Member Info for nursesteve

At the end of the presentation there was mention of the other meetings they had / let’s hope these are with various interested parties!

Https://presentations.investormeetcompany.com/conferences/97cb9ce5b047/bigroom

Wow!

On Avacta’s web page under investors, Resources, Published papers there are no results.

Given what Al has said before and the appointment of a CMO then it may be a paper is about to be published online and perhaps this will be what they have arranged the meeting to discuss?

Thank you for your reply gmcc

Thanks Timster. Would you please let me know how to find the chat group as putting AVCT or Avacta into the telegram chat search doesn’t seem to bring up a chat to do with this share or company.

My apologies to those that see this as asking the obvious.

BITL. I was medically discharged from the Army after 22 years with mental health issues so it might well do. I’m obviously missing something here. GLA

Is there a Avacta telegram group ? 🤔

?

4 partnerships announced

3 x TR1’s

2 formal bidders

1 takeover offer!

And at least one very happy shareholder! 🎄 😀

The RNS dated 19 Sept identified cohort 7 to be the final dose escalation in the phase 1a escalation study. So the review of phase 1s data should include that data and I’m hopeful that at least one more patient will have demonstrated shrinkage of their tumour. That should then make for a welcome news report. GLA

I think fizzy might be in order 🥂 5rings!

Thank you jdt1990 appreciate the reminder 👍🏻

Detailed review of Phase 1a data. The aim of phase 1a was to identify the dosage to be used for phase 1b. So at the least I’d expect that news. Having a MTD confirmed should help to shake the market awake to what’s going on here.

Unless of course they do turn up in Ribena costumes and admit it’s all a hoax? 😂

Kingalf Let’s hope for the ‘potential bullish reversal’ becoming a reality today!

Either way I’ve faith it will get a lot higher than it is at present but I think it’s just a question of when the value here gets recognised by the market. Might have to wait for an inflection point of actual sales figures and confirmation of further approved use (NHS Episwitch?) of the various tests.

It’s like blackadder Kate short for ‘bob’ 😂

But how much would you put on Avacta timing data release to coincide with the webinar Timster?

Interesting contribution Energyshares. Having followed the link it seems any IND has to have completed the phase 1 trial to be eligible. So while AVA6000 wouldn’t at present meet that requirement it would as soon as it does complete phase 1. Another route (besides AA and breakout designation?) to getting AVA6000 into those that need it.

Could we see the AVACTA announce completion of Phase 1 prior to it and then the London conference state AVA6000 is eligible under that program?

If they replicate the tumour shrinkage already announced in one patient with STS (they announced at the same time the data we are awaiting also showed additional signs of efficacy in other patients), then IMHO demand will increase exponentially. The FDA could fast track AVA6000 very quickly and big Pharma would be like Kodak faced with the choice of embracing the new tech or ignoring this.

Thanks Dug. From my quick listen it seems like this additional data will add to the library on which OBD’s tests are based (about 10:50 in on the audio). So Biobank’s news is in general a positive for us.

Biobank has released data that could be used to predict someone’s risk of disease they recruited half a million people to create a comprehensive source of health data. After five years, more than 350,000 hours of genome sequencing, and more than £200 million of investment, it has released the world’s largest single set of sequencing data. Do we think this backs up our tests? Or I does it negate them?